WASHINGTON (AP) — Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, will ...

Trump selected the former television talk show host and prominent physician in November to fill the role on his Cabinet.

Opinion: Musk, RFK Jr. drive off FDA inspectors ... using his time and power to cancel vital federal vaccine advisory committee meetings aimed at developing next season’s flu vaccine.

As the Senate Finance Committee questioned Kennedy during ... against the FDA’s restrictions on unproven health claims. “RFK has dedicated his whole life to opposing the undue influence ...

Even higher percentages are on SSRIs and benzos. We are not just overmedicating our children, we are overmedicating our entire population,” Kennedy told the Senate Finance Committee. The exact rate at ...

All seven members of the Alaska Senate’s powerful finance committee on Monday proposed rewriting the payment formula for the annual Permanent Fund dividend, renewing the Senate’s effort to ...

Mr. Kennedy never did disavow his vaccine views in the runup to Senate confirmation ... for Disease Control and Prevention’s Advisory Committee on Immunization Practices. This is the group ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HHS ...

Kennedy Jr., U.S. President Donald Trump's nominee for Secretary of Health and Human Services, testifies during his Senate Finance Committee ... are really bad." MORE: RFK Jr. wants to regulate ...

His confirmation came less than two weeks after the Republican-controlled Senate Finance Committee advanced his nomination on a 14-13 vote. All of the Democrats on the committee had opposed ...

MORE: How Bill Cassidy, a lifelong vaccination advocate, wound up voting for RFK Jr. as health secretary Kennedy's offer ... testifies during his Senate Finance Committee, Jan. 29, 2025. Win ...

During his Senate Finance Committee confirmation hearing, Kennedy indicated the administration was likely to closely scrutinize the abortion drug mifepristone because of “safety’ concerns.